Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/q/cdna/) was not found.

Search q cdna at Google

Search q cdna at Yahoo

Search q cdna at Msn

Google
 
(Date:10/12/2008)...t Bonn and Dsseldorf Universities have discovered ...he researchers investigated over 500,000 positions...ch occurs clearly more frequently in bald men than...ed in the November issue of the journal Nature Ge...8:00 London time, doi: 10.1038/ng.228). In 2005, t...
(Date:10/12/2008)...a built-in weapon against HIV, but until recently ...dy published online by the journal Nature reveal...nown as APOBEC-3G and suggests new directions for...ry human cell. It is capable of stopping HIV at th...ranscribes its RNA into viral DNA. , The study,s...
(Date:10/10/2008)...have identified stem cells with the capacity to bu... issue of the journal Cell, a Cell Press publica...s can renew themselves, transplants of the progeni...ice can restore normal fat tissue in animals that ... insight into the causes of obesity, a condition c...
(Date:10/10/2008)... October 7, 2008 The world,s top scientists and ...r in Philadelphia to present their latest research...can Society of Human Genetics (ASHG) from Tuesday,..., at the Pennsylvania Convention Center., Founded...hip organization for human genetics,specialists w...
Breaking Biology News(10 mins):Important new hair-loss gene discovered 2Body's anti-HIV drug explained 2Fat-regenerating 'stem cells' found in mice 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 3The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 4The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 5Streams natural filters if not overloaded 2489 1Streams natural filters if not overloaded 2489 2Cancer Survivors Lobby Lifetime TV to Order More of Side Order of Life 14235 1Cancer Survivors Lobby Lifetime TV to Order More of Side Order of Life 14235 2First Lady Laura Bush Joins Susan G Komen for the Cure 28R 29 to Launch Global Promise Fund Assisting Women Worldwide 14230 1First Lady Laura Bush Joins Susan G Komen for the Cure 28R 29 to Launch Global Promise Fund Assisting Women Worldwide 14230 2First Lady Laura Bush Joins Susan G Komen for the Cure 28R 29 to Launch Global Promise Fund Assisting Women Worldwide 14230 3Deloittes Connected Care Model Promotes Technologically Enabled In Home Health Care Projects Future Health Care Savings in the Billions 14224 1Deloittes Connected Care Model Promotes Technologically Enabled In Home Health Care Projects Future Health Care Savings in the Billions 14224 2Deloittes Connected Care Model Promotes Technologically Enabled In Home Health Care Projects Future Health Care Savings in the Billions 14224 3
...But apparently when it comes to birds, they have a... is genetic. Species with differentiated sex chrom... the fact that males and females get different-siz...ng act geneticists call dosage compensation. But ... shows that birds are extraordinary, because some ...
...ture now will we meet the acute water-environment-...50 years. "With earth,s water, land and human res...he future ?but it is probable that today,s food pr...ses in many parts of the world" says David Molden ... Management Institute. , This is the opening progn...
...orders and Stroke (NINDS) today is launching a lar...l supplement creatine can slow the progression of ...n approved therapy for PD or any other condition, ...ce. The potential benefit of creatine for PD was ...w rapid method for screening potential compounds. ...
...-assembly stage in which a powerful molecular moto...med shell (the capsid). How it manages this intric...hat the DNA passes into the capsid shell through a...r. Scientists have speculated that rotation of the...sid as it turns. , In a new study published onli...
Other Biology News:Bird sex is something else 2Living with water scarcity -- world must act now 2Living with water scarcity -- world must act now 3Living with water scarcity -- world must act now 4Living with water scarcity -- world must act now 5NIH announces phase III clinical trial of creatine for Parkinson's disease 2NIH announces phase III clinical trial of creatine for Parkinson's disease 3The connector rotation hypothesis? Phage do not pack their DNA by rotation 2
(Date:10/10/2008)...rstCall/ -- Synvista,Therapeutics, Inc. (Amex: SY... Federici, 49, to its Board of Directors, expandin... West Pharmaceutical Services as Vice President an... his financial leadership,West Pharmaceutical,s r...$300 million. He has more than 20 years of public ...
(Date:10/10/2008)... Do you think that the blind,can,t use computers? ...ber,17 open house at the Virginia Rehabilitation C...ow instructors there empower the blind and,visuall...rough non-visual,techniques taught at the center.,...ding an open house to,celebrate the grand opening ...
(Date:10/10/2008)...ion of a highly successful CIO Finance Summit 2008...their next business technology gathering, and this...in healthcare. CDM Media has confirmed the CIO Hea...Four Seasons Resort in Scottsdale, AZ. , ...008 -- Upon the completion of a highly successful ...
(Date:10/10/2008)...tialing Center (ANCC) has designated Geisinger Med...ame via a conference call to hospital administrato... applause., GMC joins an elite group of only 15 P...he United States that have achieved Magnet status....ecognition., "Achieving Magnet designation is a t...
Breaking Medicine News(10 mins):Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Geisinger Medical Center earns prestigious Magnet designation 2
...the Government Homeopathic Medical College in Kozh...or chikungunya.// Principal Abdul Rehman said in a...extokes and Brayonia could effectively tackle chik... in the hospital that the Andhra Pradesh Governmen...
...esearchers have identified several risk factors th...loss in children with bacterial meningitis//, acco...s of Otolaryngology - Head & Neck Surgery, one of ...meningitis is the most common reason for acquired ...
...etting fewer hours of sleep or lower-quality sleep...ol among African-Americans with diabetes//, accord...hives of Internal Medicine, a theme issue on sleep...experience a chronic lack of adequate sleep, eithe...
...pansion of the NHS ?12 billion computer system exp...ajor incidents" in four months//. These problems h...on screens in operating theatres. Details of patie... been left inaccessible on several occasions. Staf...
Other Medicine News:Health News:Risk Factors Identified for Hearing Loss in Children with Bacterial Meningitis 2Health News:Insufficient Sleep Associated with Poorer Blood Glucose Control 2Health News:NHS Inconvenienced by 110 major computer failures 2
...incipal excitatory neurotransmitter receptors in b...notropic receptors, and metabotropic receptors. Io...xes of various subunits (GluR1-7, NMDA1-3, KAI-2) ...botropic glutamate receptors are G-protein coupled...
Recommended fro Western blotting application
... KLF15 is a Cys2-His2 zinc finger gene. It is foun...t, and skeletal muscle. Accession #: NP_054798 S...s immunized with a synthetic peptide corresponding... P03590 Reconstitution and Storage: Antibody is l...
...lose) was developed in the late 1960s by Wellcome ... commercial pioneers of immunoassay in the world. ...pidly found favour with researchers and clinical b...munoassays, and became a benchmark methodology for...
Biology Products:
...ated lathing techniques, intrinsically permeable p...te lenses feature a center thickness of just 0.08 ...red Thinsite lenses maintain a 30% decrease in cen...sign eliminates stress points to reduce the chance...
Lifestyle Gp is a simultaneous vision lens with patented multi-aspheric back surface. Through a series of front and back surface curves, the LifeStyle Gp delivers up to +3.00 diopters of add. Plus, i
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle
Ophthalmic surgery stretcher. Designed for exceptional surgeon access, ideal for either superior or temporal approach.
Medicine Products:
(Date:10/10/2008)... SANTA CLARA, Calif., Oct. 10 /- Fin... and control solutions for life science process,ap... their E-Commerce Store,that makes shopping for se...n be found at the Finesse web site ( http://www.fi...purchase bioprocess sensors and accessories,on-lin...
(Date:10/10/2008)... WILMINGTON, Del., Oct. 10 /PRNewswire-FirstCall/...he U.S. Food and Drug Administration (FDA) has,app...te) Extended-Release,Tablets for the acute treatme...lar disorder, the manic and mixed episodes associa...reatment of bipolar I disorder as adjunctive,thera...
(Date:10/10/2008)... LAVAL, QC, Oct. 10 / Nept...(NASDAQ.NEPT - TSX.V.NTB) today announced,financia...August 31, 2008., Total revenue for the three-mon...pared to $2,085,000 for the first quarter ended Au... The Company substantially decreased its net loss...
(Date:10/9/2008)...,, OAK RIDGE, Oct. 9, 2008 -- New analytical to...e, the Department of Energy,s state-of-the-art neu...tory, include a beam line dedicated to nuclear phy...Beam Line (FNPB) has opened its shutter to receive...ysics studies planned for the new, intense beam li...
Breaking Biology Technology:FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9Neptune Technologies & Bioressources Inc. reports first quarter results 2Spallation Neutron Source sends first neutrons to 'Big Bang' beam line 2
... , Wis. - Ralph Kauten is taking direct aim at th...pons just passed an early test. , ,Kauten, CEO of ...rom an initial screening of its PreserveX Polymeri...mployed UGT1A1, an enzyme that metabolizes things ...er a drug will become active once inside the body,...
...e, Wis. - MatriLab, a Madison-based start-up that...ldwide wound care market, has won the 2006 Governo...as honored during an awards ceremony during the 2...of 27 finalists that presented business plans to a...the contest, which drew 200 entries, it will colle...
...e, Wis. - Norlight Telecommunications, Inc. has...security service designed to provide additional se...il Guardian,s features include an improved quarant...stomized to handle encrypted e-mails that are spec...lter can sort e-mails and attachments based on key...
...e years now, trademark owners have been battling s... and purchase of keywords (trademarks) that trigge...ulings show that the application of traditional tr...nology can be a complicated matter. , ,Online adve... on advertising triggered by the keyword (and trad...
Other Biology Technology:QBI's PreserveX product passes initial test 2QBI's PreserveX product passes initial test 3MatriLab wins Governor's Business Plan Contest 2MatriLab wins Governor's Business Plan Contest 3MatriLab wins Governor's Business Plan Contest 4Keyword advertisers win some, lose some 2Keyword advertisers win some, lose some 3Keyword advertisers win some, lose some 4Keyword advertisers win some, lose some 5
(Date:10/8/2008)...vement in patients with pulmonary arterial hy...have limited benefit for this debilitating, r...ase, -- Imatinib mesylate, available as Gleevec...o inhibit protein associated with PAH, -- Novar...ate in PAH in 2009 EAST HANOVER, N.J., Oct. ...
(Date:10/7/2008)...r detecting polyps that can be ... 7 /- At the American College of,Gast...(ACG 2008), renowned,gastroenterologist Douglas K....nal clinical study that evaluated the efficacy of ...is designed to improve the ability,of physicians t...
(Date:10/7/2008)...- Burcon NutraScience,Corporation (TSX-V: BU) anno... canola protein isolates are GRAS (Generally Recog... of food and beverage,applications. The products h... evaluation by a panel of qualified experts in the...iences, food allergies and pediatric,nutrition. Bu...
(Date:10/7/2008)...ken once-daily significantly,improved the symptoms...RNewswire-FirstCall/ -- Shire plc (LSE: SHP,Nasda...company, today,announced that a study published in...ychiatry found once-daily VYVANSE significantly im...DHD) symptoms in adults within,the first week of t...
Breaking Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Researchers find cause of severe allergic reaction to cancer drug 14220 1Researchers find cause of severe allergic reaction to cancer drug 14220 2Researchers find cause of severe allergic reaction to cancer drug 14220 3Position Statement Regarding Lt Gov Paterson from Tara A Cortes Ph D RN President and CEO of Lighthouse International 14215 1Popular Energy Drinks Cause Tooth Erosion 1510 1Popular Energy Drinks Cause Tooth Erosion 1510 2New Tools Boost Alzheimers Awareness 14206 1New Tools Boost Alzheimers Awareness 14206 2New Tools Boost Alzheimers Awareness 14206 3
...es Primary Endpoint Among High-Risk Infants Versus...edically Attended,Outpatient RSV- Related Lower Re...ewswire-FirstCall/ -- MedImmune, Inc.,today announ...l,conducted for prevention of respiratory syncytia... investigational monoclonal antibody,(MAb) also kn...
...ic Presentation for Pristiq Occurs at the 55th Ann...stetricians and,Gynecologists, COLLEGEVILLE, Pa., ...aceuticals, a division of Wyeth , presented result...q(TM) (desvenlafaxine) for,the treatment of modera...ight sweats) associated with menopause. These stud...
Other Medicine Technology:MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 2MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 3MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 4MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 5MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 6MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease 7Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6